Single-use device reprocessing market seen reaching $5.29 billion by 2030

The global market for single-use device reprocessing services is projected to grow from $2.63 billion in 2025 to $3.02 billion in 2026, with North America holding the largest share and Asia-Pacific expected to grow fastest. The report points to rising healthcare costs, more surgical procedures and expanding hospital infrastructure as key drivers.

Why it matters: - Single-use device reprocessing gives hospitals a way to cut supply costs, reduce medical waste and keep approved devices in use longer. - The market is tied to bigger shifts in healthcare spending, operating-room demand and sustainability goals. - The report frames reprocessing as a practical tool for healthcare systems trying to control costs without sacrificing safety.

What happened: - The Business Research Company published its Single-Use Device Reprocessing Services Global Market Report 2026 covering market size, trends and forecasts for 2026-2035. - The market is projected to rise from $2.63 billion in 2025 to $3.02 billion in 2026. - The report forecasts the market will reach $5.29 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Single-use device reprocessing is the industrial remanufacturing of medical devices originally intended for one-time use. - The process includes disassembly, deep chemical decontamination, component testing, recalibration and high-level sterilization using gas or plasma treatments. - Reprocessed devices are designed to meet safety and performance standards equivalent to original equipment manufacturer requirements. - Growth from 2025 to 2026 reflects pressure to control healthcare costs, wider use of sterilization and infection control protocols, more medical devices and surgical procedures, regulated reprocessing frameworks in developed countries and greater awareness of medical waste reduction. - The report also points to procurement policies that favor sustainability, automation in sterilization and testing, stronger regulatory support, demand for affordable surgical supplies and advances in precision cleaning and validation technologies. - The report says global medical cost inflation rose from 9.5% in 2024 to 10.0% in 2025 and is projected to reach 10.3% in 2026. - Asia-Pacific medical inflation is forecast to increase from 13.2% in 2025 to 14.0% in 2026. - The UK Health Security Agency reported 102,025 orthopedic surgical procedures in December 2023, up 10.2% from 92,608 a year earlier. - The American Hospital Association said community hospitals within multi-hospital systems increased from 3,510 in 2024 to 3,525 in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - The report also adds key technologies and future trend analysis. - A free sample report is available here. - The full report is available here.

Between the lines: - The forecast suggests reprocessing is moving from a niche cost-saving tactic to a more established part of hospital procurement. - The strongest demand signals come from regions and systems facing both inflation and capacity constraints. - Sustainability is no longer just a messaging point; it is becoming part of purchasing decisions.

What's next: - The market is expected to keep expanding as hospitals look for lower-cost supply options and regulators maintain or broaden support for reprocessing. - Asia-Pacific’s growth trajectory could narrow the gap with North America if procedural volumes and infrastructure investment continue to rise. - Automation and validation tools are likely to matter more as providers demand scale and compliance.